The antimalarial ferroquine: from bench to clinic
Ferroquine (FQ, SSR97193) is currently the most advanced organometallic drug candidate and about to complete phase II clinical trials as a treatment for uncomplicated malaria. This ferrocenecontaining compound is active against both chloroquine-susceptible and chloroquine-resistant Plasmodium falcip...
Main Authors: | Biot C., Nosten F., Fraisse L., Ter-Minassian D., Khalife J., Dive D. |
---|---|
Format: | Article |
Language: | English |
Published: |
EDP Sciences
2011-08-01
|
Series: | Parasite |
Subjects: | |
Online Access: | http://dx.doi.org/10.1051/parasite/2011183207 |
Similar Items
-
Ferroquine, an Ingenious Antimalarial Drug –Thoughts on the Mechanism of Action
by: Faustine Dubar, et al.
Published: (2008-11-01) -
Conception, synthèse, analyse structurale et activité antipaludique de dérivés de la ferroquine : investigation des mécanismes d'action
by: Chavain, Natascha
Published: (2008) -
Synthesis and biological evaluation of novel ferroquine and phenylequine analogues
by: Jacobs, Leon
Published: (2013) -
Coumarin-Annulated Ferrocenyl 1,3-Oxazine Derivatives Possessing In Vitro Antimalarial and Antitrypanosomal Potency
by: Mziyanda Mbaba, et al.
Published: (2021-03-01) -
Recent Advances in the Biological Investigation of Organometallic Platinum-Group Metal (Ir, Ru, Rh, Os, Pd, Pt) Complexes as Antimalarial Agents
by: Mziyanda Mbaba, et al.
Published: (2020-11-01)